Correlation Between GeneFerm Biotechnology and Li Peng

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and Li Peng at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and Li Peng into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneFerm Biotechnology Co and Li Peng Enterprise, you can compare the effects of market volatilities on GeneFerm Biotechnology and Li Peng and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of Li Peng. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and Li Peng.

Diversification Opportunities for GeneFerm Biotechnology and Li Peng

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between GeneFerm and 1447 is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and Li Peng Enterprise in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Li Peng Enterprise and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with Li Peng. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Li Peng Enterprise has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and Li Peng go up and down completely randomly.

Pair Corralation between GeneFerm Biotechnology and Li Peng

Assuming the 90 days trading horizon GeneFerm Biotechnology Co is expected to under-perform the Li Peng. But the stock apears to be less risky and, when comparing its historical volatility, GeneFerm Biotechnology Co is 1.11 times less risky than Li Peng. The stock trades about -0.02 of its potential returns per unit of risk. The Li Peng Enterprise is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  812.00  in Li Peng Enterprise on September 3, 2024 and sell it today you would lose (36.00) from holding Li Peng Enterprise or give up 4.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GeneFerm Biotechnology Co  vs.  Li Peng Enterprise

 Performance 
       Timeline  
GeneFerm Biotechnology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Li Peng Enterprise 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Li Peng Enterprise has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

GeneFerm Biotechnology and Li Peng Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneFerm Biotechnology and Li Peng

The main advantage of trading using opposite GeneFerm Biotechnology and Li Peng positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, Li Peng can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Li Peng will offset losses from the drop in Li Peng's long position.
The idea behind GeneFerm Biotechnology Co and Li Peng Enterprise pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEOs Directory
Screen CEOs from public companies around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Managers
Screen money managers from public funds and ETFs managed around the world